Vapogenix Awarded $1.5M PhII SBIR Grant to Develop Groundbreaking Therapy
11 Nov 2020 //
BIOSPACE
Apogenix to Start European Clinical Phase II Trial with Asunercept in COVID-19
28 Jul 2020 //
BIOSPACE
11 Nov 2020 //
BIOSPACE
28 Jul 2020 //
BIOSPACE